Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 01, 2022

SELL
$95.28 - $116.93 $31,442 - $38,586
-330 Reduced 19.93%
1,326 $132,000
Q3 2022

Oct 31, 2022

SELL
$95.28 - $116.93 $31,442 - $38,586
-330 Reduced 19.93%
1,326 $132,000
Q2 2022

Dec 01, 2022

SELL
$103.24 - $121.81 $26,429 - $31,183
-256 Reduced 13.39%
1,656 $185,000
Q2 2022

Aug 02, 2022

SELL
$103.24 - $121.81 $26,429 - $31,183
-256 Reduced 13.39%
1,656 $185,000
Q1 2022

Dec 01, 2022

SELL
$93.1 - $112.54 $218,691 - $264,356
-2,349 Reduced 55.13%
1,912 $212,000
Q1 2022

May 06, 2022

SELL
$93.1 - $112.54 $218,691 - $264,356
-2,349 Reduced 55.13%
1,912 $212,000
Q4 2021

Dec 01, 2022

SELL
$95.88 - $117.08 $166,831 - $203,719
-1,740 Reduced 29.0%
4,261 $477,000
Q4 2021

Feb 09, 2022

SELL
$95.88 - $117.08 $166,831 - $203,719
-1,740 Reduced 29.0%
4,261 $477,000
Q3 2021

Dec 01, 2022

SELL
$84.42 - $106.62 $114,220 - $144,256
-1,353 Reduced 18.4%
6,001 $576,000
Q3 2021

Nov 05, 2021

SELL
$84.42 - $106.62 $114,220 - $144,256
-1,353 Reduced 18.4%
6,001 $576,000
Q2 2021

Dec 01, 2022

SELL
$67.66 - $84.76 $1.16 Million - $1.46 Million
-17,198 Reduced 70.05%
7,354 $616,000
Q2 2021

Aug 06, 2021

SELL
$67.66 - $84.76 $1.16 Million - $1.46 Million
-17,198 Reduced 70.05%
7,354 $616,000
Q1 2021

Dec 01, 2022

SELL
$67.06 - $75.82 $266,228 - $301,005
-3,970 Reduced 13.92%
24,552 $1.66 Million
Q1 2021

Apr 30, 2021

SELL
$67.06 - $75.82 $266,228 - $301,005
-3,970 Reduced 13.92%
24,552 $1.66 Million
Q4 2020

Dec 01, 2022

BUY
$63.89 - $73.8 $97,623 - $112,766
1,528 Added 5.66%
28,522 $1.99 Million
Q4 2020

Feb 03, 2021

BUY
$63.89 - $73.8 $97,623 - $112,766
1,528 Added 5.66%
28,522 $1.99 Million
Q3 2020

Dec 01, 2022

BUY
$63.69 - $70.22 $129,354 - $142,616
2,031 Added 8.14%
26,994 $1.87 Million
Q3 2020

Nov 03, 2020

BUY
$63.69 - $70.22 $129,354 - $142,616
2,031 Added 8.14%
26,994 $1.87 Million
Q2 2020

Dec 01, 2022

BUY
$58.54 - $67.94 $1.38 Million - $1.61 Million
23,637 Added 1782.58%
24,963 $1.63 Million
Q2 2020

Aug 06, 2020

BUY
$58.54 - $67.94 $127,500 - $147,973
2,178 Added 9.56%
24,963 $1.63 Million
Q1 2020

Apr 24, 2020

SELL
$49.46 - $64.78 $258,379 - $338,410
-5,224 Reduced 18.65%
22,785 $1.37 Million
Q4 2019

Feb 10, 2020

BUY
$49.86 - $58.26 $565,960 - $661,309
11,351 Added 68.14%
28,009 $1.62 Million
Q3 2019

Nov 06, 2019

BUY
$47.54 - $53.43 $318,660 - $358,141
6,703 Added 67.33%
16,658 $861,000
Q2 2019

Aug 09, 2019

SELL
$46.79 - $52.47 $15,300 - $17,157
-327 Reduced 3.18%
9,955 $508,000
Q1 2019

May 13, 2019

BUY
$46.36 - $52.63 $7,139 - $8,105
154 Added 1.52%
10,282 $538,000
Q4 2018

Feb 13, 2019

SELL
$41.54 - $47.25 $61,271 - $69,693
-1,475 Reduced 12.71%
10,128 $466,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $472,416 - $517,677
10,103 Added 673.53%
11,603 $0
Q1 2018

May 07, 2018

SELL
$48.49 - $58.14 $61,630 - $73,895
-1,271 Reduced 45.87%
1,500 $74,000
Q4 2017

Feb 08, 2018

SELL
$47.53 - $53.73 $10,884 - $12,304
-229 Reduced 7.63%
2,771 $0
Q2 2017

Aug 07, 2017

BUY
N/A
3,000
3,000 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.